Skip to content

Stereotaxis STXS Capitalized Contract Costs, Net

Capitalized Contract Costs, Net at other companies

iRadimed logo
iRadimedIRMD

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:CapitalizedContractCostNet.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's capitalized contract costs, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's capitalized contract costs, net?
Stereotaxis (STXS) reported capitalized contract costs, net of $200K in Q1 2026.
How has Stereotaxis's capitalized contract costs, net changed year-over-year?
Stereotaxis's capitalized contract costs, net increased by 100.0% year-over-year, from $100K to $200K.
What is the long-term trend for Stereotaxis's capitalized contract costs, net?
Over 5 years (2020 to 2025), Stereotaxis's capitalized contract costs, net has grown at a -19.7% compound annual growth rate (CAGR), from $300K to $100K.
What does capitalized contract costs, net mean?
This reflects the incremental costs incurred to acquire or fulfill customer contracts that are deferred and amortized over the expected benefit period. It highlights the company's investment in customer acquisition and the efficiency of its sales process. Monitoring this helps investors understand the relationship between upfront sales costs and long-term revenue recognition.